TrialArthritis & rheumatology (Hoboken, N.J.)2019

A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis.

George D Kitas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.